Seeking Alpha

IMGN
  ImmunoGen, Inc. - NASDAQ

9/16/2014, 3:29 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
IMGN vs. ETF Alternatives
Company Description
Immunogen Inc is a biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
Sector: Healthcare
Industry: Biotechnology
Country: United States